TR200100700T2 - EtO2C--CH2-(R)Cgl-Aze-Pab-OH'nin kristalin formları - Google Patents

EtO2C--CH2-(R)Cgl-Aze-Pab-OH'nin kristalin formları

Info

Publication number
TR200100700T2
TR200100700T2 TR2001/00700T TR200100700T TR200100700T2 TR 200100700 T2 TR200100700 T2 TR 200100700T2 TR 2001/00700 T TR2001/00700 T TR 2001/00700T TR 200100700 T TR200100700 T TR 200100700T TR 200100700 T2 TR200100700 T2 TR 200100700T2
Authority
TR
Turkey
Prior art keywords
eto2c
aze
cgl
pab
crystalline forms
Prior art date
Application number
TR2001/00700T
Other languages
English (en)
Inventor
Edvardsson Daniel
Hedstr�m Lena
Lundblad Anita
Pettersson Ursula
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TR200100700T2 publication Critical patent/TR200100700T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

EtO2C-CH2-(R) Cgl-Aze-Pab- OH ya da bunun farmakolojik olarak kabul edilebilir bir tuzu esas itibari ile kristalin formda hazirlanmaktadir. EtO2C-CH- (R)Cgl-Aze-Pab-OH'nin kristalin formlarinin, bilesigin amorf formlari ile karsilastirildiginda daha yüksek bir kimyasal ve kati duruma sahip oldugu bulunmustur.
TR2001/00700T 1998-09-03 1999-09-02 EtO2C--CH2-(R)Cgl-Aze-Pab-OH'nin kristalin formları TR200100700T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9802974A SE9802974D0 (sv) 1998-09-03 1998-09-03 New crystalline forms

Publications (1)

Publication Number Publication Date
TR200100700T2 true TR200100700T2 (tr) 2001-07-23

Family

ID=20412468

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00700T TR200100700T2 (tr) 1998-09-03 1999-09-02 EtO2C--CH2-(R)Cgl-Aze-Pab-OH'nin kristalin formları

Country Status (39)

Country Link
US (5) US6225287B1 (tr)
EP (1) EP1107980B1 (tr)
JP (2) JP3493341B2 (tr)
KR (1) KR100629825B1 (tr)
CN (1) CN1204143C (tr)
AP (1) AP1520A (tr)
AR (1) AR029312A1 (tr)
AT (1) ATE231521T1 (tr)
AU (1) AU763421B2 (tr)
BG (1) BG105384A (tr)
BR (1) BR9913464A (tr)
CA (1) CA2341259A1 (tr)
CU (1) CU23015A3 (tr)
CZ (1) CZ2001775A3 (tr)
DE (1) DE69905054T2 (tr)
DK (1) DK1107980T3 (tr)
EA (1) EA003264B1 (tr)
EE (1) EE200100135A (tr)
ES (1) ES2192101T3 (tr)
HK (1) HK1034721A1 (tr)
HR (1) HRP20010132B1 (tr)
HU (1) HUP0104330A2 (tr)
ID (1) ID28779A (tr)
IL (1) IL141433A0 (tr)
IS (1) IS1942B (tr)
MY (1) MY121394A (tr)
NO (1) NO20011083L (tr)
NZ (2) NZ510070A (tr)
OA (1) OA11908A (tr)
PL (1) PL346544A1 (tr)
SA (1) SA99200682B1 (tr)
SE (1) SE9802974D0 (tr)
SK (1) SK2802001A3 (tr)
TR (1) TR200100700T2 (tr)
TW (1) TWI247013B (tr)
UA (1) UA66869C2 (tr)
WO (1) WO2000014110A1 (tr)
YU (1) YU17301A (tr)
ZA (1) ZA200101763B (tr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802974D0 (sv) 1998-09-03 1998-09-03 Astra Ab New crystalline forms
SE9900070D0 (sv) 1999-01-13 1999-01-13 Astra Ab New use
SE9902550D0 (sv) * 1999-07-02 1999-07-02 Astra Ab New crystalline forms
US20020115603A1 (en) * 2000-06-22 2002-08-22 Chiron Corporation Methods and compositions for the treatment of peripheral artery disease
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
WO2002030943A1 (fr) * 2000-10-12 2002-04-18 Chugai Seiyaku Kabushiki Kaisha Derive d'erythromycine possedant des nouvelles structures cristallines et procedes associes de production
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
US7129233B2 (en) 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
DE50310038D1 (de) 2002-03-11 2008-08-07 Curacyte Ag Hemmstoffe der urokinase, ihre herstellung und verwendung
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201659D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
DE10301300B4 (de) 2003-01-15 2009-07-16 Curacyte Chemistry Gmbh Verwendung von acylierten 4-Amidino- und 4-Guanidinobenzylaminen zur Inhibierung von Plasmakallikrein
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
DE10342108A1 (de) * 2003-09-11 2005-04-14 Curacyte Chemistry Gmbh Basisch-substituierte Benzylaminanaloga als Inhibitoren des Gerinnungsfaktors Xa, ihre Herstellung und Verwendung
WO2005031397A2 (en) * 2003-09-26 2005-04-07 Zetetic Institute Catoptric and catadioptric imaging systems with pellicle and aperture-array beam-splitters and non-adaptive and adaptive catoptric surfaces
US20050209211A1 (en) * 2004-03-16 2005-09-22 Devalina Law Trihemihydrate, anhydrate and novel hydrate forms of Cefdinir
WO2005091696A1 (fr) * 2004-03-29 2005-10-06 Quanta Display Inc. Structure a cadres pour module retroeclaire
US7524354B2 (en) * 2005-07-07 2009-04-28 Research Foundation Of State University Of New York Controlled synthesis of highly monodispersed gold nanoparticles
DE102006050672A1 (de) 2006-10-24 2008-04-30 Curacyte Discovery Gmbh Hemmstoffe des Plasmins und des Plasmakallikreins
TW200827336A (en) * 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030
EP2361572B1 (en) * 2010-02-26 2013-04-17 Biedermann Technologies GmbH & Co. KG Implant for stabilizing bones or vertebrae
US9550585B2 (en) 2014-06-09 2017-01-24 Space Systems/Loral, Llc Highly inclined elliptical orbit de-orbit techniques

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1075277B (it) * 1977-02-11 1985-04-22 Erba Carlo Spa Derivati insaturi e epossidici dell'acio 7-acilamido-3-cefem-4-carbossilico e procedimento per la loro preparazione
US4315011A (en) * 1978-07-12 1982-02-09 Richter Gedeon Vegyeszeti Gyar Rt. 1-Alkyl-9-bromohexahydroindolo quinolizium salts and use thereof to increase blood flow
EP0052963B1 (en) * 1980-11-20 1985-02-20 Beecham Group Plc Secondary amines
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
SE504185C2 (sv) * 1994-11-08 1996-12-02 Astra Ab Lagringsstabil vattenlösning för infusion av trombininhibitorer
TW541316B (en) * 1995-12-21 2003-07-11 Astrazeneca Ab Prodrugs of thrombin inhibitors
US5830805A (en) * 1996-11-18 1998-11-03 Cornell Research Foundation Electroless deposition equipment or apparatus and method of performing electroless deposition
SE9802974D0 (sv) * 1998-09-03 1998-09-03 Astra Ab New crystalline forms

Also Published As

Publication number Publication date
CU23015A3 (es) 2005-01-25
ZA200101763B (en) 2002-06-03
WO2000014110A1 (en) 2000-03-16
EP1107980A1 (en) 2001-06-20
JP3493341B2 (ja) 2004-02-03
ES2192101T3 (es) 2003-09-16
EE200100135A (et) 2002-06-17
US6888007B2 (en) 2005-05-03
HRP20010132A2 (en) 2002-02-28
BR9913464A (pt) 2001-06-12
DK1107980T3 (da) 2003-04-22
US20010023244A1 (en) 2001-09-20
US6440939B2 (en) 2002-08-27
US20060287249A1 (en) 2006-12-21
CN1325406A (zh) 2001-12-05
DE69905054D1 (de) 2003-02-27
NZ524486A (en) 2004-10-29
NO20011083L (no) 2001-05-03
US20050153901A1 (en) 2005-07-14
IS5870A (is) 2001-02-28
YU17301A (sh) 2004-05-12
CA2341259A1 (en) 2000-03-16
US6225287B1 (en) 2001-05-01
ATE231521T1 (de) 2003-02-15
MY121394A (en) 2006-01-28
US20050054579A9 (en) 2005-03-10
KR20010088795A (ko) 2001-09-28
AP2001002078A0 (en) 2001-03-31
CZ2001775A3 (cs) 2001-10-17
DE69905054T2 (de) 2003-11-06
EA200100194A1 (ru) 2001-10-22
AU6014799A (en) 2000-03-27
TWI247013B (en) 2006-01-11
NZ510070A (en) 2003-04-29
AP1520A (en) 2005-12-28
JP2002524467A (ja) 2002-08-06
SK2802001A3 (en) 2001-09-11
EP1107980B1 (en) 2003-01-22
PL346544A1 (en) 2002-02-11
SE9802974D0 (sv) 1998-09-03
EA003264B1 (ru) 2003-02-27
HUP0104330A2 (hu) 2002-04-29
UA66869C2 (uk) 2004-06-15
KR100629825B1 (ko) 2006-09-29
OA11908A (en) 2006-04-10
IS1942B (is) 2004-08-13
BG105384A (en) 2001-11-30
SA99200682B1 (ar) 2006-08-22
IL141433A0 (en) 2002-03-10
US20030017992A1 (en) 2003-01-23
ID28779A (id) 2001-07-05
HK1034721A1 (en) 2001-11-02
CN1204143C (zh) 2005-06-01
HRP20010132B1 (en) 2004-06-30
NO20011083D0 (no) 2001-03-02
AR029312A1 (es) 2003-06-25
AU763421B2 (en) 2003-07-24
JP2004075687A (ja) 2004-03-11

Similar Documents

Publication Publication Date Title
TR200100700T2 (tr) EtO2C--CH2-(R)Cgl-Aze-Pab-OH'nin kristalin formları
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
PT1109812E (pt) Pirrolobenzodiazepinas
TR199700844T1 (tr) Pirazolil-Benzoil Türevleri.
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
TR200100432T2 (tr) Hepatit C inhibitörü tri-peptidler
AU4064597A (en) Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
AP2002002637A0 (en) Novel piperazine
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
AU1676200A (en) Polyhydroxylated heterocyclic derivatives as anti-coagulants
BR0014651A (pt) Inibidores de adesão de célula mediada por "alfa" l beta2
SE9702773D0 (sv) Novel compounds
TR200002605T2 (tr) Nitrik oksit sentaz inhibitörleri olarak faydalı halojene amidino amino asit türevleri
TR200002237T2 (tr) Benzotiyadiazol ve türevleri
TR199900486T2 (tr) Aziniloksi ve fenoksi-diaril-karbonasit türevleri.
NZ515757A (en) Amorphous compounds and their pharmaceutical compositions
TR199902283T2 (tr) Ikame edilmis izokuinolin türevleri ve bunlarin antikonvulsant olarak kullanimi.
AU7824900A (en) Compounds and methods for inhibiting mrp1
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
TR200200070T2 (tr) Titanyum-türevli bileşikler, bunların hazırlanması ve kullanımı.
AU5727899A (en) Diaminocyclobutene-3,4-dione derivatives, their preparation and use
BR9915692A (pt) Monohidrato de bromidrato de eletriptano
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
DK1056754T3 (da) Phosphatderivater af diaryl-1,3,4-oxadiazolon
MX9906657A (es) Composicion agroquimica granular humedecible o soluble en agua.